Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Held

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMIKatarina Mars, Sophia Humphries, Philip Leissner, et al.
Circulation|June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial FibrillationAbhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Circulation. Arrhythmia and Electrophysiology|January 27, 2016
Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) TrialAn H Bui, Christopher P Cannon, Philippe Gabriel Steg, et al.
European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.
European Journal of Preventive Cardiology|December 18, 2015
Tooth loss is independently associated with poor outcomes in stable coronary heart diseaseOla Vedin, Emil Hagström, Andrzej Budaj, et al.
International Journal of Cardiology|July 25, 2017
Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart diseaseOla Vedin, Emil Hagström, Ollie Östlund, et al.
European Heart Journal|April 1, 2017
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trialMarco Valgimigli, Francesco Costa, Yuliya Lokhnygina, et al.
European Heart Journal|June 3, 2017
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trialEmmanuelle Vidal-Petiot, Amanda Stebbins, Karen Chiswell, et al.
REC, Interventional Cardiology|May 26, 2025
Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular CollaboratoryErnest Spitzer, José M de la Torre Hernández, Ingibjörg Jóna Guðmundsdóttir, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMIKatarina Mars, Sophia Humphries, Philip Leissner, et al.
Circulation|June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial FibrillationAbhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.
European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Circulation. Arrhythmia and Electrophysiology|January 27, 2016
Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) TrialAn H Bui, Christopher P Cannon, Philippe Gabriel Steg, et al.
European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.
European Journal of Preventive Cardiology|December 18, 2015
Tooth loss is independently associated with poor outcomes in stable coronary heart diseaseOla Vedin, Emil Hagström, Andrzej Budaj, et al.
International Journal of Cardiology|July 25, 2017
Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart diseaseOla Vedin, Emil Hagström, Ollie Östlund, et al.
European Heart Journal|April 1, 2017
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trialMarco Valgimigli, Francesco Costa, Yuliya Lokhnygina, et al.
European Heart Journal|June 3, 2017
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trialEmmanuelle Vidal-Petiot, Amanda Stebbins, Karen Chiswell, et al.
REC, Interventional Cardiology|May 26, 2025
Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular CollaboratoryErnest Spitzer, José M de la Torre Hernández, Ingibjörg Jóna Guðmundsdóttir, et al.
Pageof 23